| Antidepressants for patients with tinnitus P Baldo, C Doree, P Molin, D McFerran, S Cecco Cochrane database of systematic reviews, 2012 | 338 | 2012 |
| An historical overview over Pharmacovigilance G Fornasier, S Francescon, R Leone, P Baldo International journal of clinical pharmacy 40, 744-747, 2018 | 218 | 2018 |
| mTOR pathway and mTOR inhibitors as agents for cancer therapy P Baldo, S Cecco, E Giacomin, R Lazzarini, B Ros, S Marastoni Current cancer drug targets 8 (8), 647-665, 2008 | 155 | 2008 |
| An update of efficacy and safety of cetuximab in metastatic colorectal cancer: a narrative review G Fornasier, S Francescon, P Baldo Advances in therapy 35, 1497-1509, 2018 | 105 | 2018 |
| Pharmacovigilance in oncology P Baldo, G Fornasier, L Ciolfi, I Sartor, S Francescon International Journal of Clinical Pharmacy 40, 832-841, 2018 | 93 | 2018 |
| Interferon‐alpha for maintenance of follicular lymphoma P Baldo, M Rupolo, A Compagnoni, R Lazzarini, A Bearz, R Cannizzaro, ... Cochrane Database of Systematic Reviews, 2010 | 55 | 2010 |
| Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance G Fornasier, M Taborelli, S Francescon, J Polesel, M Aliberti, P De Paoli, ... International Journal of Clinical Pharmacy 40, 795-802, 2018 | 52 | 2018 |
| Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives S Cecco, E Muraro, E Giacomin, D Martorelli, R Lazzarini, P Baldo, ... Current cancer drug targets 11 (1), 85-102, 2011 | 47 | 2011 |
| Safety and efficacy evaluation of albumin-bound paclitaxel S Cecco, M Aliberti, P Baldo, E Giacomin, R Leone Expert opinion on drug safety 13 (4), 511-520, 2014 | 45 | 2014 |
| Amatuximab and novel agents targeting mesothelin for solid tumors P Baldo, S Cecco OncoTargets and therapy, 5337-5353, 2017 | 37 | 2017 |
| Pharmacovigilance in oncology: evaluation of current practice and future perspectives P Baldo, P De Paoli Journal of Evaluation in Clinical Practice 20 (5), 559-569, 2014 | 33 | 2014 |
| Patient-centered cancer care programs in Italy: Benchmarking global patient education initiatives I Truccolo, C Cipolat Mis, S Cervo, L Dal Maso, M Bongiovanni, A Bearz, ... Journal of Cancer Education 31, 405-412, 2016 | 26 | 2016 |
| Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology P Baldo, S Francescon, G Fornasier International journal of clinical pharmacy 40, 748-753, 2018 | 24 | 2018 |
| A centralized pharmacy unit for cytotoxic drugs in accordance with Italian legislation P Baldo, A Bertola, G Basaglia, M Moneghini, R Sorio, E Zibardi, ... Journal of evaluation in clinical practice 13 (2), 265-271, 2007 | 19 | 2007 |
| Pharmacovigilance of anti-cancer medicines: opportunities and challenges D Crestan, MP Trojniak, S Francescon, G Fornasier, P Baldo Expert Opinion on Drug Safety 19 (7), 849-860, 2020 | 18 | 2020 |
| Toxicities and adverse drug reactions experienced during anticancer treatment: it is desirable to consider the problem within the international system of pharmacovigilance P Baldo, G Fornasier, S Francescon, E Ferrarin, I Truccolo, P De Paoli Journal of Clinical Oncology 33 (25), 2824-2825, 2015 | 15 | 2015 |
| Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data A Ossato, V Damuzzo, P Baldo, D Mengato, M Chiumente, A Messori Cancer Medicine 12 (3), 2155-2165, 2023 | 14 | 2023 |
| Biosimilar oncology drugs in Europe: Regulatory and pharmacovigilance considerations S Francescon, G Fornasier, P Baldo Oncology and Therapy 4, 173-182, 2016 | 14 | 2016 |
| Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice S Orzetti, F Tommasi, A Bertola, G Bortolin, E Caccin, S Cecco, E Ferrarin, ... International Journal of Molecular Sciences 23 (6), 3012, 2022 | 12 | 2022 |
| EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies S Francescon, G Fornasier, P Baldo International Journal of Clinical Pharmacy 40, 778-782, 2018 | 12 | 2018 |
